This latter finding contrasts with the observation that metformin leaves unaltered free thyroid hormone levels [34], and possibly reflects an effect played by obesity on thyroid hormone metabolism either mediated by type 2 deiodinase activity, TH binding to TBG, or thyroxine degradation. The gene discussed is TG; the disease is obesity due to melanocortin 4 receptor deficiency.